Tablet pack
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view of a tablet pack showing our new design;
FIG. 2 is a perspective view thereof, with the flap in an open position;
FIG. 3 is a rear elevational view of FIG. 2;
FIG. 4 is a left side elevational view of FIG. 2;
FIG. 5 is a top plan view of FIG. 2; and,
FIG. 6 is a bottom plan view of FIG. 2.
Referenced Cited
Patent History
Patent number: D344018
Type: Grant
Filed: Oct 22, 1991
Date of Patent: Feb 8, 1994
Assignee: Glaxo Group Limited (Greenford)
Inventors: Stephen F. Kelsey (London), Lucien A. Warner (London)
Primary Examiner: Prabhakar G. Deshmukh
Law Firm: Darby & Darby
Application Number: 7/782,256
Type: Grant
Filed: Oct 22, 1991
Date of Patent: Feb 8, 1994
Assignee: Glaxo Group Limited (Greenford)
Inventors: Stephen F. Kelsey (London), Lucien A. Warner (London)
Primary Examiner: Prabhakar G. Deshmukh
Law Firm: Darby & Darby
Application Number: 7/782,256
Classifications
Current U.S. Class:
D/9346;
D/9432